REFERENCES
1.
Odaman
AI, Bayram C, Koc B, Ersoy G, Pasli UE, Aki H, et al. Burkitt Leukemia
With Precursor B-Cell Immunophenotype and Dual Translocation of t(14;18)
and t(8;14) in a Child: Case Report and Review of the Literature. J
Pediatr Hematol Oncol. 2020 2020-01-01;42(1):e61-3.
2.
Jacobson
C, LaCasce A. How I treat Burkitt lymphoma in adults. BLOOD. 2014
2014-11-06;124(19):2913-20.
3.
Herbrueggen
H, Mueller S, Rohde J, Arias PL, Moericke A, Attarbaschi A, et al.
Treatment and outcome of IG-MYC(+) neoplasms with precursor B-cell
phenotype in childhood and adolescence. LEUKEMIA. 2020
2020-03-01;34(3):942-6.
4.
Polyatskin
IL, Artemyeva AS, Krivolapov YA. [Revised WHO classification of tumors
of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid
tumors]. Arkh Patol. 2019 2019-01-20;81(3):59-65.
5.
Bennett
JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al.
Proposals for the classification of the acute leukaemias.
French-American-British (FAB) co-operative group. Br J Haematol. 1976
1976-08-01;33(4):451-8.
6.
Bene
MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals
for the immunological classification of acute leukemias. European Group
for the Immunological Characterization of Leukemias (EGIL). LEUKEMIA.
1995 1995-10-01;9(10):1783-6.
7.
Lilljebjorn
H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von
Palffy S, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged
subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.
NAT COMMUN. 2016 2016-06-06;7:11790.
8.
Blum
KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. BLOOD.
2004 2004-11-15;104(10):3009-20.
9.
Shen
S, Cai J, Chen J, Xue H, Pan C, Gao Y, et al. Long-term results of the
risk-stratified treatment of childhood acute lymphoblastic leukemia in
China. HEMATOL ONCOL. 2018 2018-10-01;36(4):679-88.
10. de
Barrios O, Meler A, Parra M. MYC’s Fine Line Between B Cell Development
and Malignancy. CELLS-BASEL. 2020 2020-02-24;9(2).
11.
Habib
T, Park H, Tsang M, de Alboran IM, Nicks A, Wilson L, et al. Myc
stimulates B lymphocyte differentiation and amplifies calcium signaling.
J CELL BIOL. 2007 2007-11-19;179(4):717-31.
12.
Davis
M, Malcolm S, Rabbitts TH. Chromosome translocation can occur on either
side of the c-myc oncogene in Burkitt lymphoma cells. NATURE. 1984
1984-03-15;308(5956):286-8.
13.
Roix
JJ, McQueen PG, Munson PJ, Parada LA, Misteli T. Spatial proximity of
translocation-prone gene loci in human lymphomas. NAT GENET. 2003
2003-07-01;34(3):287-91.
14.
Navid
F, Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, et al.
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and
FAB L3 morphology associated with a B-precursor immunophenotype: the
Pediatric Oncology Group experience. LEUKEMIA. 1999
1999-01-01;13(1):135-41.
15.
Sakaguchi
K, Imamura T, Ishimaru S, Imai C, Shimonodan H, Fujita N, et al.
Nationwide study of pediatric B-cell precursor acute lymphoblastic
leukemia with chromosome 8q24/MYC rearrangement in Japan. PEDIATR BLOOD
CANCER. 2020 2020-07-01;67(7):e28341.
16.
Hunger
SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J
Med. 2015 2015-10-15;373(16):1541-52.
17.
Colin
VM, Auperin A, Pillon M, Burke A, Anderson J, Barkausk D, et al. Results
of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for
Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL)
and Mature Acute Leukemia (B-AL). Pediatric blood & cancer.
2016;63(Suppl.3):S31.
18.
Wagener
R, Lopez C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, et al. IG-MYC
(+) neoplasms with precursor B-cell phenotype are molecularly distinct
from Burkitt lymphomas. BLOOD. 2018 2018-11-22;132(21):2280-5.
19.
Kuppers
R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell
lymphomas. ONCOGENE. 2001 2001-09-10;20(40):5580-94.